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n Heart Failure-Related
ospitalizations
ang et al. (1), using National Hospital Discharge Survey data,
howed a steady increase in heart failure hospitalizations from
979 to 2004. More than 80% were elderly (age 65 years). The
edian hospital stay and proportion of in-hospital deaths declined
uring this period. This declining mortality was related to im-
rovement in medical therapy and widespread availability of
evascularization procedures.
Over the last 3 decades, a novel syndrome, heart failure with
reserved systolic function (diastolic dysfunction), has been in-
reasingly recognized. This predominantly involves the elderly and
s responsible for approximately 50% of heart failures in this group
2,3). Fang et al. (1) did not mention left ventricular function in
heir report, and the impact of diastolic heart failure in their
onclusions is speculation.
Recent epidemiologic data have confirmed the increasing preva-
ence and hospitalization of patients with diastolic dysfunction (3).
ver the last 2 decades, there have been significant advances in the
anagement of heart failure, but these have almost exclusively focused
n a population with systolic dysfunction. Survival among patients
ith preserved ejection fraction has been shown to be better than that
mong those with reduced ejection fractions (4,5).
In their report, the investigators highlighted an increase in the
ospitalization of women with heart failure, relative to men.
iven the generally older female U.S. population, patients with
iastolic dysfunction have consistently been shown to more
ikely be female (5,6).
Therefore, the increase in the prevalence of diastolic heart
ailure likely has a major contribution to the findings of Fang et al.
1) and may entirely account for the increase in hospitalization, the
ged population, the gender discrepancy, as well as the demon-
trated improved survival.
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eply
e would like to thank Dr. Sorrell and colleagues for their
nterest in our work (1). The primary objective of our study was
o use national surveillance data to examine annual hospitaliza-
ion rates and trends in characteristics for patients hospitalized
ith heart failure as either the first-listed diagnosis or addi-
ional (second to seventh) diagnosis, as well as to assess the
rends in other clinical conditions that lead to hospitalization
mong patients with any mention of heart failure. Thus, we did
ot present data on left ventricular ejection fraction or speculate
n the impact of systolic or diastolic ventricular function in our
onclusions. In fact, the National Hospital Discharge Survey
ontains no information for any measurement of left ventricu-
ar function.
We agree with Dr. Sorrell and colleagues that a substantial
roportion of patients have heart failure with preserved systolic
unction and that this proportion has increased over time (2). We
ould like to use International Classification of Diseases–Ninth
evision–Clinical Modification (ICD-9-CM) codes to identify
eart failure with systolic heart failure (ICD-9-CM 428.2) and
iastolic heart failure (ICD-9-CM 428.3). Unfortunately, these
odes were not in effect until 2003. Previously, both conditions
ere coded as 428.0. The data showed that the percentages of
ecorded isolated systolic heart failure were 1.2%, 1.7%, and 1.8%
or 2003, 2004, and 2005, respectively, and the corresponding
ercentages for isolated diastolic heart failure were 3.0%, 4.3%, and
.5%, respectively. Although the percentages for diastolic heart
ailure were more than twice those of systolic heart failure, neither
ontributed a significant proportion to total heart failure. How-
ver, as pointed out by Dr. Sorrell and colleagues, women had a
igher proportion of isolated diastolic heart failure than men (4.7%
s. 3.0%, p 0.001) and had a lower proportion of isolated systolic
eart failure (1.2% vs. 2.0%, p  0.001). Because only 3 years of
ospitalization data are available for identifying systolic heart
ailure and diastolic heart failure separately, we are unable to
resent 25-year trends.
c
p
i
*
N
G
J
*
4
A
E
R
1
2
E
N
T
O
W
i
T
w
d
r
r
a
k
a
p
b
t
c
l
i
(
b
p
d
p
a
t
a
I
W
N
C
s
p
t
p
B
n
t
i
o
p
m
N
Y
D
*
*
‘
3
t
E
R
1
2
3
4
R
W
w
o
t
p
S
3
r
T
458 Correspondence JACC Vol. 53, No. 5, 2009
February 3, 2009:457–9Therefore, with the limitations of the National Hospital Dis-
harge Survey, we are unable to conclude that the increase in the
revalence of diastolic heart failure contributed to the finding of
ncreasing heart failure hospitalization over the past 25 years.
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levated N-Terminal Pro-B-Type
atriuretic Peptide Levels:
he Effect of Chronic
bstructive Pulmonary Disease
e read with great interest the recent article by Daniels et al. (1)
n which the investigators reported that detectable cardiac troponin
and N-terminal pro-B-type natriuretic peptide (NT-proBNP)
ere both associated with increased all-cause and cardiovascular
eath in healthy older adults.
NT-proBNP was previously identified as a prognostic cardiac
isk marker associated with increased mortality. NT-proBNP is
eleased by cardiac myocytes in response to wall stress in conditions
ssociated with volume overload as in heart failure and chronic
idney disease, pressure overload as in patients with heart valve
bnormalities, and ischemia owing to coronary disease. In the
resent study, the association remained even after participants with
aseline coronary heart disease were excluded, which was 30% of
he subjects with elevated (450 pg/ml) NT-proBNP levels.
However, the authors might have overlooked the effect of
hronic obstructive pulmonary disease (COPD) on NT-proBNP
evels. COPD is associated with cardiovascular disease and is an
ndependent risk factor for cardiovascular morbidity and mortality
2). We recently investigated the relationship between COPD,
oth the presence and severity, and NT-proBNP levels in 376
atients. To mitigate the influence of heart failure, chronic kidney
isease, and myocardial ischemia, we adjusted for history of angina
ectoris, myocardial infarction, heart failure, and renal function. In
ddition, all patients had resting left ventricular function of more
han 40% using echocardiography. The severity of COPD was assessed using pulmonary function tests with the GOLD (Global
nitiative for Chronic Obstructive Lung Disease) classification.
e found COPD to be an independent risk factor for increased
T-proBNP levels, and the levels increased with the severity of
OPD.
The underlying mechanism is likely to be pulmonary hyperten-
ion and right ventricular dysfunction caused by pulmonary arterial
ressure overload (3). COPD may induce wall stretching, ven-
ricular dilation, and/or increased vascular pressures, which may
romote the secretion of the neurohormone NT-proBNP.
ecause COPD is common in the elderly population (affecting
early 35% of this population) (4), the addition of spirometric data
o the analysis by Daniels et al. (1) would have been very
nteresting and informative. The less severe forms of COPD are
ften asymptomatic and therefore frequently underestimated, es-
ecially in the elderly. Thus, the presence of underlying COPD
ight have contributed to the observed correlation between
T-proBNP and outcome in this elderly population.
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eply
e thank Dr. van Gestel and colleagues for their interest in our
ork (1). They wonder whether the presence of underlying chronic
bstructive pulmonary disease (COPD) might have contributed to
he strong association between N-terminal pro-B-type natriuretic
eptide (NT-proBNP) and outcomes in the Rancho Bernardo
tudy. We did not find this to be the case.
Dr. Van Gestel and colleagues stated that COPD affects nearly
5% of the elderly population; however, the article that they
eference actually found this incidence only in current smokers (2).
he cumulative incidence of COPD was only 14% in ex-smokers
nd 12% in never-smokers.
